|
|
Correlation Between Bone Metabolism Indicators and Thyroid Hormones in Patients with Hyperthyroidism and Predictive Value on Hyperthyroidism Osteoporosis |
MA Xingpo, NIU Min, SHEN Jinfu, et al |
Fuyang People's Hospital, Anhui Fuyang 236000, China |
|
|
Abstract Objective: To observe the changes of bone metabolism in patients with hyperthyroidism and their relationship with thyroid hormones and hyperthyroid osteoporosis. Methods: 176 patients with hyperthyroidism who were admitted from September 2017 to September 2020 were selected as hyperthyroidism group, and 100 healthy controls were selected as control group. The thyroid hormones [total triiodothyronine (TT3), free triiodothyronine (FT3), total thyroxine (TT4), free thyroxine (FT4), thyroid-stimulating hormone (TSH)] and bone metabolism indexes [25-hydroxyvitamin D [25-(OH)-D], total aminoterminal propeptide of type I procollagen (TPINP), β-Crosslaps (β-CTX), N-terminal osteocalcin (N-MID)] were compared between the two groups. Pearson correlation analysis was used to analyze the correlation between bone metabolism indexes and thyroid hormones. Bone mineral density (BMD) was used to evaluate whether hyperthyroidism were complicated with osteoporosis. Based on this, the patients were divided into osteoporosis group and non-osteoporosis group. The differences of the above bone metabolism indexes were compared between the two groups, and receiver operating characteristic (ROC) curve was plotted to analyze the predictive value of bone metabolism indexes on hyperthyroid osteoporosis. Results: The levels of serum TT3, FT3, TT4 and FT4 in hyperthyroidism group were significantly higher than those in control group (P<0.05), while the TSH level was significantly lower than that in control group (P<0.05). The 25-(OH)-D level was significantly lower than that in control group (P<0.05), while the levels of TPINP, β-CTX and N-MID were significantly higher than those in control group (P<0.05). Serum 25-(OH)-D in patients with hyperthyroidism was negatively correlated with TT3, FT3, TT4 and FT4 (P<0.05). TPINP was positively correlated with FT3 and FT4 (P<0.05). β-CTX was positively correlated with TT3, FT3, TT4 and FT4 (P<0.05), and was negatively correlated with TSH (P<0.05). N-MID was positively correlated with TT3, FT3, TT4 and FT4 (P<0.05), and was negatively correlated with TSH (P<0.05). The detection rate of osteoporosis among 176 patients with hyperthyroidism was 23.30% (41 cases). The level of 25-(OH)-D in osteoporosis group was significantly lower than that in non-osteoporosis group (P<0.05), while the levels of TPINP, β-CTX and N-MID were significantly higher than those in non-osteoporosis group (P<0.05). The areas under the ROC curves (AUC) of 25-(OH)-D, TPINP, β-CTX and N-MID in predicting hyperthyroid osteoporosis were 0.660, 0.721, 0.641 and 0.639 (P<0.05), and the AUC of the combination of the four was 0.786 (P<0.05). Conclusion: Serum 25-(OH)-D of patients with hyperthyroidism is abnormally decreased, while TPINP, β-CTX and N-MID are abnormally increased, and the above indexes are closely related to the levels of thyroid hormones. The combined detection of 25-(OH)-D, TPINP, β-CTX and N-MID has a certain predictive value on hyperthyroid osteoporosis.
|
|
|
|
|
[1] 郭赫,倪青.甲状腺功能亢进症康复治疗进展[J].北京中医药,2018,37(8):763~767. [2] 朱于青,孙琳.促甲状腺激素与骨代谢[J].中国医师杂志,2019,21(2):315~318. [3] 付晓宁.骨代谢生化指标对于骨质疏松症诊断与治疗的临床意义[J].中国骨与关节损伤杂志,2018,33(9):1003~1005. [4] 张萌萌,张秀珍,邓伟民,等.骨代谢生化指标临床应用专家共识(2019)[J].中国骨质疏松杂志,2019,25(10):1357~1372. [5] 中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组.中国甲状腺疾病诊治指南-甲状腺功能亢进症[J].中华内科杂志,2007,46(10):876~882. [6] 张弢,于扬,隋淼,等.甲亢患者血清瘦素脂联素水平与甲状腺激素和骨代谢指标的关系[J].河北医学,2020,26(1):28~33. [7] 覃海恋,李双蕾,陈文辉,等.甲亢性骨质疏松的中西医研究进展[J].中国骨质疏松杂志,2020,26(8):159~162. [8] 段秋琴,陈桂金,王玉月.甲状腺功能亢进症患者治疗前,后血清骨代谢,钙磷代谢水平和甲状腺功能变化及其临床意义[J].广西医科大学学报,2019,36(9):1480~1483. [9] 田志,杨召旭,范静,等.老年骨折患者血清25OHD和PTH水平与骨质疏松程度的相关性[J].重庆医学,2018,47(6):53~55. [10] 赵长英,甘西伦,王明霜,等.维生素D缺乏与Graves病及其并发症关系的临床研究[J].重庆医科大学学报,2018,43(6):814~818. [11] 靳晓萍,韩莉,詹先琴,等.甲亢患者骨钙素和甲功、骨密度及脂代谢指标相关性研究[J].新疆医科大学学报,2019,42(5):78~82. [12] 王云秀,薛元霞,陈月萍,等.骨代谢指标在老年女性原发性骨关节炎中骨质疏松症的诊断价值[J].热带医学杂志,2018,18(12):1573~1575,1606. |
|
|
|